From: Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system
Drugs or therapy | Regulatory signal | References |
---|---|---|
SA-49 | PKCα/GSK3β/MITF | [47] |
TBM-1 | TFEB | [49] |
IPAG | Sigma 1 | [44] |
2-BP | DHHC3 | [45] |
PD-LYSO | HIP1R | [46] |
STM108 | EGFR/B3GNT3 | [51] |
H1A | CMTM6 | [43] |
Verteporfen | Palmitoylation, glycosylation | [52] |
Curcumin | Palmitoylation, glycosylation\STAT\proteasome | [123] |
Pitstop 2 | Recycle | [124] |
Ivermectin | Changes in redistribution, macromolecular interactions | [125] |
Diformin | Isolation of PD-L1 in endosomes or autophagosomes | [126] |
Amlodipine | Target PD-L1 to lysosome | [127] |
LYTAC | Lysosomal targeting chimaera, extracellular proteins | [128] |